Results 31 to 40 of about 180,829 (383)

On the markers for schizophrenia

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2021
Summary. The study of various markers indicating an imbalance in both the neurotransmitter and immune systems observed in patients with schizophrenia is currently of great scientific and practical interest.
A. N. Erichev, I. I. Bode, V. O. Polyakova, A. P. Kotsubinsky, B. G. Butoma   +4 more
doaj   +1 more source

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

The Lancet Rheumatology, 2021
Background B-cell-depleting therapies increase the risk of morbidity and mortality due to COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting therapies are scarce.
M. Moor, F. Suter-Riniker, M. Horn, D. Aeberli, J. Amsler, B. Möller, L. Njue, C. Medri, A. Angelillo-Scherrer, L. Borradori, S. Radonjic‐Hoesli, S. S. Seyed Jafari, A. Chan, R. Hoepner, V. Bacher, Laila-Yasmin Mani, J. Iype, C. Hirzel, B. Maurer, D. Sidler   +19 more
semanticscholar   +1 more source

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology [PDF]

Journal of Clinical and Diagnostic Research, 2017
Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly.
Anisha Mohanpuria, Vijay Kumar, Pooja Suteri, Sadhna Marwah, Abhay Shankar Nigam   +4 more
doaj   +1 more source

Ovarian Diffuse Large B-cell Lymphoma Initially Suspected Dysgerminoma Managed by Laparoscopic Staging Surgery

Gynecology and Minimally Invasive Therapy, 2020
Ovarian diffuse large B-cell lymphoma (DLBCL) is rare. DLBCL is a complex type of lymphoma. The ovarian DLBCL usually harbor a favorable prognosis. We report a case of ovarian DLBCL that presented as an ovarian mass with lower abdominal pain and was ...
Pei- Chen Li, Pei Qi Lim, Yung- Hsiang Hsu, Dah- Ching Ding   +3 more
doaj   +1 more source

Monoclonal antibodies targeting CD20 [PDF]

mAbs, 2013
Letter to the Editor: We are commenting on the article by Klein et al. on the functional properties of several anti-CD20 monoclonal antibodies (mAbs) in the January/February 2013 issue of this journal.1 Rituximab, the first monoclonal antibody approved for cancer therapy, has truly revolutionized the treatment of a variety of CD20+ hematological ...
Chang, Chien-Hsing, Rossi, Edmund A., Goldenberg, David M.   +2 more
openaire   +2 more sources

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

RMD Open, 2022
Background Immune responses on SARS-CoV-2 vaccination in patients receiving anti-CD20 therapies are impaired but vary considerably. We conducted a systematic review and meta-analysis of the literature on SARS-CoV-2 vaccine induced humoral and cell ...
S. Schietzel, M. Anderegg, A. Limacher, A. Born, M. Horn, B. Maurer, C. Hirzel, D. Sidler, M. Moor   +8 more
semanticscholar   +1 more source

Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells [PDF]

, 2015
Natural killer (NK) immune cells mediate antibody-dependent cellular cytotoxicity (ADCC) by aggregating FcγRIIIA/CD16, contributing significantly to the therapeutic effect of CD20 monoclonal antibodies (mAb).
Capuano, Cristina, Cimino, Giuseppe, Galandrini, Ricciarda, Molfetta, Rosa, Paolini, Rossella, Pighi, Chiara, Rago, Angela, Romanelli, Maddalena, Santoni, Angela   +8 more
core   +1 more source

Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study

Clinical Infectious Diseases, 2021
Background Patients treated with anti-CD20 therapy are particularly at risk of developing severe COVID-19, however little is known regarding COVID-19 vaccine effectiveness in this population.
Natacha Madelon, K. Lauper, G. Bréville, Irène Sabater Royo, R. Goldstein, D. Andrey, A. Grifoni, A. Sette, L. Kaiser, C. Siegrist, A. Finckh, P. Lalive, A. Didierlaurent, C. Eberhardt   +13 more
semanticscholar   +1 more source

Posttransplant lymphoproliferative disorders in neuronal xenotransplanted macaques [PDF]

, 2016
Posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of lymphoid proliferations that occur in the setting of depressed T-cell function due to immunosuppressive therapy used following solid organ transplantation, hematopoietic ...
Aron Badin, R., Cavicchioli, L., Cozzi, E., Crossan, C., Danesi, A., Ferraresso, S., Hantraye, P., Kaliyaperumal, S., Knight, H., Scobie, L., Trez, D., Vadori, M., Westmoreland, S.   +12 more
core   +1 more source

Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis

European Respiratory Journal, 2022
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease associated with chronic inflammation and tissue remodelling leading to fibrosis, reduced pulmonary function, respiratory failure and death.
C. Prêle, Tylah Miles, D. Pearce, R. O’Donoghue, C. Grainge, L. Barrett, Kimberly A Birnie, A. Lucas, S. Baltic, M. Ernst, Catherine A. Rinaldi, G. Laurent, Darryl A. Knight, M. Fear, G. Hoyne, R. McAnulty, S. Mutsaers   +16 more
semanticscholar   +1 more source